Germany Genetic Testing Market Outlook to 2024

  • ID: 4428961
  • Report
  • Region: Germany
  • 50 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc
  • Myriad Genetics Inc
  • PerkinElmer Inc
  • Qiagen NV
  • MORE
Germany Genetic Testing Market Outlook to 2024

Summary

The new report, Germany Genetic Testing Market Outlook to 2024, provides key market data on the Germany Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Genetic Testing market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the Germany Genetic Testing market.
  • Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories and Luminex Corp.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Hologic Inc
  • Myriad Genetics Inc
  • PerkinElmer Inc
  • Qiagen NV
  • MORE
1 Table of Contents

2 Introduction
2.1 What Is This Report About?
2.2 Genetic Testing Market Segmentation
2.3 Definitions of Markets Covered in the Report

3 Genetic Testing Market, Germany
3.1 Genetic Testing Market, Germany, Revenue ($m), 2010-2017
3.2 Genetic Testing Market, Germany, Revenue ($m), 2017-2024
3.3 Genetic Testing Market, Germany, Distribution Share by Revenue ($m), 2017
3.4 Genetic Testing Market, Germany, Company Share by Revenue ($m), 2017

4 Overview of Key Companies in Germany, Genetic Testing Market
4.1 Abbott Laboratories
4.1.1 Company Overview
4.2 F. Hoffmann-La Roche Ltd
4.2.1 Company Overview
4.3 Qiagen NV
4.3.1 Company Overview
4.4 PerkinElmer Inc
4.4.1 Company Overview
4.5 Myriad Genetics Inc
4.5.1 Company Overview
4.6 Hologic Inc
4.6.1 Company Overview

5 Genetic Testing Market Pipeline Products

6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Cathay Fortune International to Acquire Epigenomics
6.2 Debt Offerings
6.2.1 Epigenomics Raises USD8.5 Million in Private Placement of Bonds
6.3 Equity Offerings
6.3.1 Epigenomics Raises USD6.5 Million in Private Placement of Shares
6.3.2 Siemens Healthcare May Raise up to USD47.3 Billion in IPO
6.3.3 Siemens Healthcare Plans IPO of Shares
6.4 Partnerships
6.4.1 Qiagen and Centogene Enter into Co-Marketing Agreement
6.4.2 LifeCodexx Enters into Research Agreement with Charite - Universitatsmedizin Berlin
6.4.3 Lucigen Enters into Distribution Agreement with Illumina
6.4.4 Analytik Jena Enters into Co-Development Agreement with Illumina
6.5 Venture Financing
6.5.1 Centogene Raises USD28 Million in Series A Financing

7 Recent Developments
7.1 Corporate Communications
7.1.1 Sep 19, 2017: Esteemed Researcher and Clinical Oncologist W. Michael Korn, M.D. Joins Caris Life Sciences as Chief Medical Officer
7.1.2 Mar 31, 2017: Company Founder and Analytik Jena Executive Board Member Klaus Berka Steps Down from the Operational Business
7.2 Financial Announcements
7.2.1 Jul 18, 2017: ECG-Guard Helps Users to Take Control of Their Health Through an Intuitive Mobile App
7.2.2 Jul 06, 2017: Epigenomics issues change in guidance for financial year 2017
7.2.3 May 10, 2017: Epigenomics announces 2017 First Quarter Financial Results
7.2.4 Apr 26, 2017: Epigenomics Reports Results for Financial Year 2016
7.2.5 Nov 09, 2016: Epigenomics Announces 2016 Third Quarter and Nine Months Financial Results and Reports on Operational Highlights
7.3 Legal And Regulatory
7.3.1 Jul 31, 2017: Cumberland Pharmaceuticals Begin U.S. Shipments Of Dexrazoxane For Oncology Patient Support
7.3.2 Jan 27, 2017: CENTOGENE successfully renewed accreditation from College of American Pathologists
7.3.3 Dec 06, 2016: Eurofins Genomics receives notice of accreditation from CAP for new laboratory in Louisville
7.3.4 Nov 08, 2016: CENTOGENE received Illumina Propel Certification for Core and Service Labs
7.4 Other Significant Developments
7.4.1 Sep 19, 2017: Agena Bioscience Announces Molecular Health As The First Interpretation Software Provider For MassARRAY Insights
7.4.2 Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers
7.4.3 Jun 27, 2017: Eurofins Genomics announces the US launch of Plasmid Verification Services
7.4.4 May 05, 2017: Another milestone is reached for the new headquarter in Rostock
7.4.5 May 03, 2017: 23andMe and German Pain Specialist Grunenthal Explore the Genetics of Pain to Help Identify New Treatments for Patients
7.4.6 Apr 26, 2017: SYNLAB and Counsyl Enter Into Agreement to Offer Genetic Screening for Serious Inherited Health Conditions in Europe and Latin America
7.4.7 Mar 06, 2017: Biolog Announces Appointment of New Distributor in Germany and Austria
7.4.8 Feb 01, 2017: Genetic Associates to collaborate with CENTOGENE for the Australian and New Zealand Markets
7.4.9 Jan 06, 2017: Parkinson’s Institute and Clinical Center partners with CENTOGENE to characterize Parkinson’s patients with targeted gene panel
7.4.10 Nov 17, 2016: Eurofins Genomics Looks to Disrupt DNA Synthesis Market with Smaller-Scale, High-Throughput Service Featuring Rapid Turnaround and Lower Price
7.4.11 Oct 27, 2016: New England Biolabs Announces Agreement with AmpTec GmbH to supply key mRNA Synthesis Reagents
7.5 Product News
7.5.1 Apr 24, 2017: CENTOGENE adds extends single gene analyses and NGS panels
7.5.2 Apr 20, 2017: Pelvic floor descent repair with modern mesh implants: The benefits outweigh the acceptable risks
7.5.3 Feb 27, 2017: European Patent Office To Grant CRISPR-Cpf1 Patent To Broad Institute, MIT, And Harvard University
7.5.4 Feb 08, 2017: Bioline Launches New JetSeq DNA Library Preparation Kits
7.5.5 Jan 16, 2017: CENTOGENE extends its test portfolio
7.6 Strategy And Business Planning
7.6.1 Aug 17, 2017: TATAA Biocenter Expands Its Real-Time PCR Offerings With Analytik Jena’s qTOWER3

8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact
8.4 Disclaimer

List of Tables
Table 1: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017
Table 2: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 3: Genetic Testing Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2017
Table 4: Genetic Testing Market, Germany, Company Share by Revenue ($m), USD Constant, 2017
Table 5: Genetic Testing Market Pipeline Products
Table 6: Cathay Fortune International to Acquire Epigenomics
Table 7: Epigenomics Raises USD8.5 Million in Private Placement of Bonds
Table 8: Epigenomics Raises USD6.5 Million in Private Placement of Shares
Table 9: Siemens Healthcare May Raise up to USD47.3 Billion in IPO
Table 10: Siemens Healthcare Plans IPO of Shares
Table 11: Qiagen and Centogene Enter into Co-Marketing Agreement
Table 12: LifeCodexx Enters into Research Agreement with Charite - Universitatsmedizin Berlin
Table 13: Lucigen Enters into Distribution Agreement with Illumina
Table 14: Analytik Jena Enters into Co-Development Agreement with Illumina
Table 15: Centogene Raises USD28 Million in Series A Financing
Table 16: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country

List of Figures
Figure 1: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 2: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 3: Genetic Testing Market, Germany, Company Share (%) 2017
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Qiagen NV
  • PerkinElmer Inc
  • Myriad Genetics Inc
  • Hologic Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll